Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of DTPa-IPV/Hib and DTPa-HBV-IPV/Hib Vaccines in Infants
NCT00325143Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2003
- Primary completion
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of pertussis filamentous haemagglutinin, diphtheria + tetanus + acellular pertussis + inactivated poliomyelitis + Haemophilus influenzae type b vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by GSK. Started Dec 2003; status: completed.
02
Drugs
pertussis filamentous haemagglutinindiphtheria + tetanus + acellular pertussis + inactivated poliomyelitis + Haemophilus influenzae type b vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT00325143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325143.